KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
$0.555
+0.0050 (+0.91%)
At Close: Apr 26, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Mar 01, 2024 Buy 2 250 000 Israel Biotech Fund I, L.p. Warrants
Mar 01, 2024 Buy 1 500 000 Israel Biotech Fund I, L.p. Convertible Promissory Note
Mar 01, 2024 Sell 3 750 000 Israel Biotech Fund I, L.p. Rights
Mar 01, 2024 Buy 2 250 000 Israel Biotech Fund I, L.p. Warrants
Mar 01, 2024 Buy 1 500 000 Israel Biotech Fund I, L.p. Convertible Promissory Note
Mar 01, 2024 Sell 3 750 000 Israel Biotech Fund I, L.p. Rights
Feb 07, 2024 Buy 8 062 500 Israel Biotech Fund I, L.p. Common Stock, par value $0.001 per share
Feb 07, 2024 Sell 2 586 905 Israel Biotech Fund I, L.p. Common Stock, par value $0.001 per share
Feb 07, 2024 Buy 8 437 500 Israel Biotech Fund I, L.p. Common Stock, par value $0.001 per share
Feb 07, 2024 Sell 2 707 581 Israel Biotech Fund I, L.p. Common Stock, par value $0.001 per share
Feb 07, 2024 Buy 1 295 813 Israel Biotech Fund I, L.p. Common Stock, par value $0.001 per share
Feb 07, 2024 Sell 4 237 687 Israel Biotech Fund I, L.p. Convertible Promissory Note
Feb 07, 2024 Buy 4 237 687 Israel Biotech Fund I, L.p. Common Stock, par value $0.001 per share
Feb 07, 2024 Buy 3 887 438 Israel Biotech Fund I, L.p. Common Stock, par value $0.001 per share
Feb 07, 2024 Sell 1 295 813 Israel Biotech Fund I, L.p. Convertible Promissory Note
Feb 07, 2024 Sell 1 926 221 Israel Biotech Fund I, L.p. Convertible Promissory Note
Feb 07, 2024 Sell 8 062 500 Israel Biotech Fund I, L.p. Warrants
Feb 07, 2024 Sell 3 887 438 Israel Biotech Fund I, L.p. Convertible Promissory Note
Feb 07, 2024 Buy 1 926 221 Israel Biotech Fund I, L.p. Common Stock, par value $0.001 per share
Feb 07, 2024 Sell 8 437 500 Israel Biotech Fund I, L.p. Warrants
Nov 17, 2023 Buy 10 312 500 Israel Biotech Fund I, L.p. Rights
Nov 17, 2023 Buy 4 687 500 Israel Biotech Fund I, L.p. Rights
Nov 17, 2023 Buy 3 150 000 Israel Biotech Fund I, L.p. Rights
Nov 17, 2023 Buy 3 150 000 Israel Biotech Fund I, L.p. Rights
Nov 17, 2023 Buy 5 625 000 Israel Biotech Fund I, L.p. Warrants
Nov 17, 2023 Buy 6 187 500 Israel Biotech Fund I, L.p. Warrants
Nov 17, 2023 Buy 6 187 500 Israel Biotech Fund I, L.p. Warrants
Nov 17, 2023 Buy 2 812 500 Israel Biotech Fund I, L.p. Warrants
Nov 17, 2023 Buy 0 Israel Biotech Fund I, L.p. Convertible Promissory Note
Nov 17, 2023 Buy 0 Israel Biotech Fund I, L.p. Convertible Promissory Note
Oct 18, 2023 Buy 0 Cabilly Yuval Common Stock, par value $0.001 per share
Oct 18, 2023 Buy 0 Cabilly Yuval Common Stock, par value $0.001 per share
Oct 18, 2023 Buy 0 Golan Roy
Oct 18, 2023 Buy 0 Orbach Pini
Oct 18, 2023 Buy 0 Martell Bridget A
Oct 18, 2023 Buy 658 858 Israel Biotech Fund I, L.p. Common Stock, par value $0.001 per share
Oct 18, 2023 Buy 658 858 Israel Biotech Fund I, L.p. Common Stock, par value $0.001 per share
Oct 18, 2023 Sell 0 Amoon Growth Fund Limited Partnership Common Stock
Sep 01, 2023 Buy 0 Israel Biotech Fund I, L.p. Convertible Promissory Note
Sep 01, 2023 Buy 0 Israel Biotech Fund I, L.p. Convertible Promissory Note
Sep 01, 2023 Buy 0 Israel Biotech Fund I, L.p. Convertible Promissory Note
Sep 01, 2023 Buy 0 Israel Biotech Fund I, L.p. Convertible Promissory Note
Jan 19, 2023 Buy 0 Israel Biotech Fund I, L.p. Common Stock, par value $0.001 per share
Jan 19, 2023 Buy 0 Israel Biotech Fund I, L.p. Common Stock, par value $0.001 per share
Jan 19, 2023 Buy 0 Amoon Growth Fund Limited Partnership Common Stock
Jan 19, 2023 Buy 2 342 Sidransky David Stock Option
Jan 19, 2023 Buy 46 Sidransky David Common Stock
Jan 19, 2023 Buy 3 279 Goldberg Murray A Stock Option
Jan 19, 2023 Buy 2 342 Goldberg Murray A Stock Option
Jan 19, 2023 Buy 1 171 Goldberg Murray A Stock Option
Jan 19, 2023 Buy 1 639 Bisker-leib Vered Stock Option
Jan 19, 2023 Buy 1 171 Bisker-leib Vered Stock Option
Jan 19, 2023 Buy 3 279 Spiegel Robert J. Stock Option
Jan 19, 2023 Buy 2 342 Spiegel Robert J. Stock Option
Jan 19, 2023 Buy 1 171 Spiegel Robert J. Stock Option
Jan 19, 2023 Buy 0 Goldberg Murray A
Jan 19, 2023 Buy 0 Goldberg Murray A
Jan 19, 2023 Buy 0 Bisker-leib Vered
Jan 19, 2023 Buy 0 Bisker-leib Vered
Jan 19, 2023 Buy 0 Spiegel Robert J.
Jan 19, 2023 Buy 0 Spiegel Robert J.
Feb 11, 2021 Buy 50 000 Gitelman Igor Employee Stock Option (right to buy)
May 04, 2020 Buy 50 000 Henderson Molly Options
May 04, 2020 Buy 13 000 Khleif Samir N Options
May 04, 2020 Buy 13 000 Appel Roni Options
May 04, 2020 Buy 50 000 Berlin Kenneth A Options
May 04, 2020 Buy 13 000 Patton James P Option
May 04, 2020 Buy 13 000 Sidransky David Option
May 04, 2020 Buy 13 000 Berman Richard J Option
May 04, 2020 Buy 50 000 Gutierrez Andres Options
Mar 13, 2020 Sell 2 401 Appel Roni Common Stock
Mar 12, 2020 Sell 200 Appel Roni Common Stock
Mar 11, 2020 Sell 399 Appel Roni Common Stock
Oct 24, 2019 Buy 25 000 Gutierrez Andres Option
Oct 24, 2019 Buy 10 000 Berman Richard J Option
Oct 24, 2019 Buy 10 000 Sidransky David Option
Oct 24, 2019 Buy 25 000 Henderson Molly Option
Oct 24, 2019 Buy 10 000 Appel Roni Options
Oct 24, 2019 Buy 10 000 Khleif Samir N Options
Oct 24, 2019 Buy 50 000 Berlin Kenneth A Option
Oct 24, 2019 Buy 10 000 Patton James P Option
Apr 11, 2019 Buy 3 750 Gutierrez Andres Common Stock
Apr 11, 2019 Buy 2 500 Henderson Molly Common Stock
Apr 10, 2019 Buy 3 000 Appel Roni Common Stock
Apr 09, 2019 Buy 2 900 Henderson Molly Common Stock
Apr 09, 2019 Buy 100 Henderson Molly Common Stock
Apr 08, 2019 Buy 2 100 Berlin Kenneth A Common Stock
Apr 08, 2019 Buy 1 100 Berlin Kenneth A Common Stock
Apr 08, 2019 Buy 800 Berlin Kenneth A Common Stock
Nov 05, 2018 Buy 30 000 Sidransky David Option
Nov 05, 2018 Buy 125 000 Henderson Molly Option
Nov 05, 2018 Buy 320 000 Berlin Kenneth A Option
Nov 05, 2018 Buy 25 000 Khleif Samir N Options
Nov 05, 2018 Buy 25 000 Appel Roni Options
Nov 05, 2018 Buy 25 000 Patton James P Option
Nov 05, 2018 Sell 3 963 Petit Robert Common Stock
Nov 05, 2018 Buy 150 000 Petit Robert Option
Nov 05, 2018 Buy 125 000 Gutierrez Andres Option
Nov 05, 2018 Buy 25 000 Berman Richard J Option
Nov 02, 2018 Sell 8 491 Petit Robert Common Stock
JSON CSV
INSIDER POWER
26.427
Last 100 transactions
Buy: 80 077 407 | Sell: 40 657 099 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 26.427.

In total, the insiders bought 80 077 407 and sold 40 657 099 ADXS shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 10.86% $52.28
LPLA Apr 19 0.743% $262.59
DOOR Apr 18 0.160% $131.39
LNG Apr 17 0.389% $156.81
FCN Apr 16 2.95% $207.62
ELV Apr 16 5.28% $506.97
DXC Apr 08 0.767% $20.87
AKR Apr 05 5.63% $16.53
ITCI Apr 05 6.84% $68.44
SARK Mar 28 13.80% $26.88
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT